ObjectiveAssess interpretative variation in Nottingham grading using control charts (CCs) and in silico kappa (ISK).MethodsIn house invasive breast cancer cases (2011-2019) at two institutions with a synoptic report were extracted. Pathologist interpretative rates (PIRs) were calculated and normed for Nottingham grade (G) and its components (tubular score (TS), nuclear score (NS), mitotic score (MS)) for pathologists interpreting >35 cases. ISKs were calculated using the ordered mutually exclusive category assumption (OMECA) and maximal categorical overlap assumption (MCOA).ResultsThe study period included 1,994 resections. Ten pathologists each assessed 38-441 cases and together saw 1,636; these were further analyzed. The PIR medians (norm...
We recently reported that nuclear grading in prostate cancer is subject to a strong confirmation bia...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Breast cancer treatment is largely guided by the results of tumor tissue analyses, i.e. evaluation o...
The prognostic value of cytonuclear grade in ductal carcinoma in situ (DCIS) is debated, partly due ...
Context: Breast carcinoma grade, as determined by the Nottingham Grading System (NGS), is an importa...
Three pathologists reviewed slides and reports of cancers arising in both the study and control popu...
Purpose: A considerable part of ductal carcinoma in situ (DCIS) lesions may never progress into inva...
OBJECTIVE: Disagreement in mammographic breast density (MBD) assessment can impact breast cancer ris...
Aim: To find out utility of grading breast carcinoma on fine needle aspiration cytology (FNAC) as pe...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Copyright © 2005 American Cancer SocietyBACKGROUND Numeric grading systems have been validated for t...
Background: This study aims to determine the pathologists ’ agreement of modified Black nuclear grad...
Methods: Clinical and pathological data of 694 patients <61 years with primary unilateral T1-4N0M0 b...
We recently reported that nuclear grading in prostate cancer is subject to a strong confirmation bia...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...
Breast cancer treatment is largely guided by the results of tumor tissue analyses, i.e. evaluation o...
The prognostic value of cytonuclear grade in ductal carcinoma in situ (DCIS) is debated, partly due ...
Context: Breast carcinoma grade, as determined by the Nottingham Grading System (NGS), is an importa...
Three pathologists reviewed slides and reports of cancers arising in both the study and control popu...
Purpose: A considerable part of ductal carcinoma in situ (DCIS) lesions may never progress into inva...
OBJECTIVE: Disagreement in mammographic breast density (MBD) assessment can impact breast cancer ris...
Aim: To find out utility of grading breast carcinoma on fine needle aspiration cytology (FNAC) as pe...
Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast c...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Copyright © 2005 American Cancer SocietyBACKGROUND Numeric grading systems have been validated for t...
Background: This study aims to determine the pathologists ’ agreement of modified Black nuclear grad...
Methods: Clinical and pathological data of 694 patients <61 years with primary unilateral T1-4N0M0 b...
We recently reported that nuclear grading in prostate cancer is subject to a strong confirmation bia...
Adjuvant chemotherapy decisions in breast cancer are increasingly based on the pathologist's assessm...
Histopathological assessment of ductal carcinoma in situ, a nonobligate precursor of invasive breast...